E thnic differences in cardiac arrhythmia incidence have been reported, with higher incidence of sudden cardiac death and lower incidence of atrial fibrillation in African Americans compared with Americans of European ancestry. 1-3 These differences have been independent of measured environmental and behavioral factors and therefore attributed to differences in genetic makeup, although the specific genetic determinants have not been identified. 3, 4 Rare nonsynonymous genetic variants in cardiac ion channel genes have been found more often in African Americans than in European Americans, 5 some of which have been associated with arrhythmia risk and myocardial electrophysiological characteristics. 6
With regard to myocardial electrophysiological characteristics, myocardial repolarization time has been established to be of particular importance for arrhythmia risk. Prolongation of the myocardial repolarization time, as measured by the electrocardiographic QT interval, confers increased risk of sudden cardiac death, 7 whereas shortening of the atrial repolarization time has been associated with atrial fibrillation. 8 Furthermore, QT interval has been shown to be highly heritable in individuals of both European 9 and African ancestry, 10 resulting from genetic determination by rare variants, common genetic variants, or both. Thus, ancestral differences in repolarization time might account for the observed pattern of ethnic differences in arrhythmia incidence. We therefore formed a consortium of African American cohorts with information on QT interval duration and genome-wide single-nucleotide polymorphism (SNP) data. Two hypotheses-first whether genetic ancestry is associated with QT interval and second whether common genetic variants are associated with QT interval duration in African Americans-were tested in a genome-wide association (GWA) study.
Material and Methods

Study Samples
The study included 10 cohorts of self-reported African ancestry with genome-wide SNP data as part of the Continental Origins and Genetic Epidemiology Network, the Candidate-Gene Association Resource consortium, and the Women's Health Initiative (WHI) SNP Health Association Resource. The 4 cohorts genotyped as part of the Candidate-Gene Association Resource consortium-Atherosclerosis Risk in Communities study, 11 Cleveland Family Study, 12 Jackson Heart Study, 13 and Multi-Ethnic Study of Atherosclerosis 14 -have been described previously, 15 as have the Continental Origins and Genetic Epidemiology Network cohorts: Bogalusa Heart Study, 16 Baltimore Longitudinal Study of Aging, 17, 18 Cardiovascular Health Study, 19 Health, Aging and Body Composition Study (Health ABC), 20, 21 Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS), 22 and the WHI. 23 Additional cohort descriptions are available in the online-only Data Supplement Methods. Genotyping, quality control, calculation of eigenvectors, and imputation in the 4 cohorts of the Candidate-Gene Association Resource consortium have been detailed previously 15, 24 and are summarized along with other cohorts in onlineonly Data Supplement Table I . The study protocol was approved by the Institutional Review Boards of participating institutions. Only individuals who provided informed consent for genetic testing were included. The authors had full access to the data and take responsibility for their integrity. All authors have read and agreed to the article as written.
Electrocardiographic Measurements
Twelve-lead ECGs with standard electrode placements were recorded with a paper speed of 25 mm per second during 10 seconds in all cohorts using either MAC PC, MAC6 (Cleveland Family Study), MAC5000 (Baltimore Longitudinal Study of Aging), MAC5500 (HANDLS), or MAC1200 (Multi-Ethnic Study of Atherosclerosis) machines (GE Healthcare, Milwaukee, WI). QT and RR interval durations were measured electronically using either the Marquette 12SL algorithm or the MC MEANS algorithm (Jackson Heart Study).
Phenotype Modeling
We excluded individuals on the basis of missing measurements of QT or RR interval duration, atrial fibrillation or flutter, left or right bundle-branch block, QRS duration ≥120 ms, intraventricular conduction delay, or a pacemaker implant. In both ancestry and GWA analyses, adjustment was performed for age, sex, RR interval, and study site in multicenter cohorts (Atheroscloerosis Risk in Communities, Cardiovascular Heart Study, Health ABC, Multi-Ethnic Study of Atherosclerosis, and WHI) in linear regression models.
Ancestry Analysis
In the 4 Candidate-Gene Association Resource cohorts, individual estimates of the proportion of African relative to European ancestry was calculated from 3192 independent ancestry informative markers included on the Affymetrix 6.0 array using the Markov Chain Monte Carlo algorithm implemented in ANCESTRYMAP 25 as in previous studies. 3, 15 Ancestry estimates were calculated from 656 852 autosomal markers using the maximum likelihood algorithm implemented in frappe 26 (which has been demonstrated to be robust to linkage disequilibrium [LD]) in WHI and the modelbased clustering algorithm of STRUCTURE 27 in Health ABC and HANDLS, including 1335 independent ancestry informative markers 28 and 279 967 markers after LD-based pruning (r 2 <0.5) from the Illumina 1 mol/L array, respectively. To test the association of this measure of continental ancestry with QT interval, QT interval was regressed linearly on ancestry estimates with adjustment for the covariates listed above and association tested using likelihoodratio or Wald tests. Heterogeneity was assessed across cohorts and results combined using the rmeta package for R (R Foundation for Statistical Computing, Vienna, Austria).
GWA Analysis
Genetic association analyses were performed in each cohort using multiple linear regression models under an additive genetic model, using various statistical software packages as shown in online-only Data Supplement Table I . Directly genotyped SNPs were tested where available; otherwise imputed genotypes were used to achieve a common set of SNPs across cohorts for the combined analysis and to improve coverage. For the family-based Cleveland Family Study, association was assessed using linear mixed-effects models as implemented in the GWAF package for R. 15 Pedigrees were confirmed using identity by state or identity by descent estimates. The Jackson Heart Study contains a family-based subcohort, but use of family-based methods had minimal effects on inflation in preliminary analyses for a set of traits, so linear regression was used as in previous studies. 15 Adjustment for the first 10 or 2 (Health ABC) eigenvectors of genetic variation was performed in study-specific regression models to account for population substructure. Eigenvectors were calculated individually in each cohort using PLINK (HANDLS) or EIGENSTRAT (all other cohorts). Cohort-specific GWA results were combined using fixed-effects meta-analysis with inverse variance weights. Genomic control was applied to results from each cohort before meta-analysis and in the combined results. A genome-wide significance threshold of 2.5×10 -8 was prespecified based on a Bonferroni-adjusted threshold of P<0.05, assuming 2 million independent common variant tests in genomes of individuals of African ancestry as previously suggested. 15, 29 Effect heterogeneity across cohorts was assessed by Cochran's χ 2 test of heterogeneity and the I 2 test. 30, 31 To identify multiple, independent signals within the same region, LD pruning was performed, whereby independent signals were defined as at least 2 genome-wide significant SNPs in low LD (r 2 <0.05) in the same 1000 kb region. Starting with the index SNP, defined as the most significant result, all surrounding genome-wide significant SNPs within 1000 kb with a pairwise r 2 ≥0.05 were placed into a bin with the index SNP using LD patterns from a 1:1 ratio of the HapMap European CEU sample and the Yoruba YRI sample. The procedure was repeated until all genome-wide SNPs were assigned membership into a bin.
Results
Baseline characteristics of the 10 study cohorts are shown in Table 1 . Hierarchical exclusions are shown in online-only Data Supplement Table II . Participants were predominantly middle aged and with a higher proportion of women. The proportion of variation in QT interval (r 2 ) explained by basic covariates (age, sex, RR interval) was relatively high, largely attributable to RR interval, ranging from 0.44 to 0.67 as shown in Table 1 .
Genetic Ancestry and QT Interval
Ancestry estimates were available in 7 cohorts, including 12 097 individuals. The distribution of estimated proportion of African ancestry relative to European ancestry was roughly similar across cohorts as shown in Table 2 . Significant heterogeneity of effects was detected across cohorts (P for heterogeneity = 0.03), as shown in online-only Data Supplement Figure I , and hence cohorts were combined using randomeffects meta-analysis. Overall, there was no association of continental ancestry with QT interval in the combined sample (P=0.94).
GWA Study
A meta-analysis of the 10 GWA studies was performed, including 13 105 individuals with typed or imputed genotypes for 2.8 million SNPs. Mild inflation of test statistics was observed with an overall genomic inflation factor (λ GC ) estimate of 1.03. After genomic control, there was a slight excess of low probability values ( Figure 1 ). A total of 19 SNPs passed genome-wide significance (P<2.5×10 -8 ), as shown in Table 3 and Figure 2 . No evidence of significant heterogeneity was observed, after accounting for 19 tests (P>0.0026), as shown in Table 3 . Cohortspecific results are shown in online-only Data Supplement Table  III . All 19 SNPs were noncoding and located on chromosome 1 at 2 loci separated by 7 megabases; 17 SNPs upstream of the NOS1AP gene and 2 SNPs upstream of ATP1B1.
With LD clustering of the 17 genome-wide significant SNPs upstream of NOS1AP, we identified 2 separate signals that were in very low LD (r 2 <0.05) in Yoruban (YRI) and European (CEU) HapMap samples; 1 signal marked by rs12143842, (minor allele frequency = 0.20), which was also the strongest SNP in GWA studies in individuals of European ancestry and with a similar effect, 32-34 and a second signal marked by rs4657175 (minor allele frequency = 0.33, r 2 to rs12143842 <0.01 in YRI). rs4657175 was also strongly correlated with an independent signal previously reported in the QTGEN study 32 (rs12029454, r 2 =0.81 in YRI), which also reached genome-wide significance in our study. Both SNPs were directly genotyped or imputed with high accuracy in all cohorts (observed/expected variance >0.9). No effect heterogeneity was observed for rs12143842 (I 2 =0.32, P=0. 21) , and nominally significant heterogeneity was observed for rs4657175 (I 2 =0.51, P=0.05).
The 2 genome-wide significant SNPs upstream of ATP1B1 were in very strong LD (r 2 in YRI: 1.0) but were not correlated with the ATP1B1 variant previously identified in the QTSCD study, 33 rs10919071 (r 2 =0.02 in CEU, monomorphic in YRI). Indeed, rs10919071 was not significantly associated with QT interval in African Americans (minor allele frequency = 0.03, P=0.07), although it had a similar effect estimate in the same direction (β coefficient = 2.08 ms per minor allele). The most significant SNP at the locus in the current study, rs1320976, showed no evidence of effect heterogeneity (I 2 =0, P=0.71) and was directly genotyped in all cohorts, except in 4 of the smaller cohorts (Bogalusa Heart Study, Baltimore Longitudinal Study of Aging, Health ABC, and HANDLS).
Several additional SNPs at loci identified in GWA studies in individuals of European ancestry also reached low P values (P<10 -5 ) in African Americans, including SNPs near LITAF (rs8049607), PLN (rs11752626), KCNQ1 (rs231906), and KCNH2 (rs3778872), as shown in online-only Data Supplement Table IV . The same SNP near LITAF showed the most significant association at the locus in blacks (P=7×10 -7 ), whereas SNPs near PLN (P=2×10 -6 ), KCNQ1 (P=2×10 -6 ), and KCNH2 (P=3×10 -6 ) showed strong-to-modest correlation with the most significant SNPs at these loci in studies of individuals with European ancestry. [32] [33] [34] Results in African Americans for top SNPs at each of the 12 loci from GWA studies in individuals of European ancestry are shown in online-only Data Supplement Table V . 
Discussion
This study examined the association of genetically inferred continental ancestry and genetic polymorphisms on cardiac repolarization, as measured by the electrocardiographic QT interval, in several large cohorts of African Americans. We observed no overall evidence of association for QT interval with proportion of individual African ancestry inferred from genome-wide data. In a GWA study including 13 105 blacks, we observed genome-wide significant associations with SNPs at 2 loci (NOS1AP, ATP1B1) and consistent associations (P<10 -5 ) for SNPs at 4 additional loci (LITAF, PLN, KCNQ1, and KCNH2) previously associated with QT interval in individuals of European ancestry. [32] [33] [34] Although the P values for association were modest, the direction of effect for the top SNP at each of the 12 previously reported loci was the same, consistent with modest power to detect mostly true underlying effects. The most significant association in NOS1AP, rs12143842, was the same SNP reported by 3 previous GWA studies of QT in populations of European descent. [32] [33] [34] Furthermore, the variant we identified in the ATP1B1 locus was independent from the previously reported SNP, 33 consistent with a second signal of association.
Genetic Ancestry
In contrast to our findings, a shorter average QT interval in individuals of self-reported African ancestry compared with self-reported European ancestry was observed in a small subset of the ARIC study 35 and in a large cohort of inpatients and outpatients from the electronic medical records of the Vanderbilt University Medical Center. 36 Both studies accounted for differences in heart rate using Bazett formula, which is explicitly discouraged in current guidelines for ECG interpretation 37 and can under-or overcorrect the influence of heart rate on QT interval. 38 A previous study from the WHI adjusting for heart rate using linear regression did not observe differences in QT interval by self-reported ancestry. 39 Our study has some advantages over these previous studies. First, our derivation of ancestry from genome-wide genetic data reduced bias resulting from the ambiguity of self-reported ancestry and allowed treatment of ancestry as a continuous variable. Second, our use of multiple population-based cohorts reduced bias resulting from ethnic differences in access and utilization of health care and allowed consistency in methodology used for ascertainment and measurement of QT interval. Third, our metaanalysis of several large cohorts allowed adequate power to detect strong or modest ancestral effects. Fourth, our use of continuous ECG measurements of QT and RR intervals allowed adjustment for heart rate using regression modeling techniques, which are well known to be more stable across the entire range of QT interval than Bazett formula. 37 Thus, our findings from several large population cohorts that QT interval adjusted for major covariates is not associated with the proportion of African ancestry based on whole-genome SNP suggest that observations in the 2 previous studies might reflect chance, selection bias, measurement bias, or other confounding influences that contribute to between-race comparisons rather than within-race proportion genetic ancestry analyses. However, our findings do not rule out a small effect.
Common Genetic Variants and QT Interval
GWA studies in samples of European ancestry have to date reported 12 loci associated with QT interval (onlineonly Data Supplement Table V) , with multiple independent signals at least at 1 locus (NOS1AP). [32] [33] [34] 40 Our findings establish with genome-wide significance that SNPs at 2 of these loci on chromosome 1-ATP1B1 and 2 signals at †African ancestry refers to the proportion of African compared with European ancestry, presented as median and interquartile range. NOS1AP-associate with QT interval in African Americans as well, with the strongest association for the same SNP upstream of NOS1AP conferring a similar QT prolongation as in previous studies (≈3 ms per minor allele copy). Furthermore, we observed low P-values (P<10 -5 ) for SNPs at 4 additional loci previously reported in populations of European descent. These observations provide additional support for a similar genetic architecture for myocardial repolarization time in individuals of African and European ancestry. For NOS1AP and LITAF, the identical SNP showed the strongest association, whereas top SNPs near PLN, KCNQ1, and KCNH2 were correlated with top SNPs from studies in individuals of European ancestry. In contrast, the 2 SNPs upstream of ATP1B1 of genome-wide significance were not correlated with the SNP from studies in individuals of European ancestry, which itself was not associated with QT interval in African Americans. This finding could reflect ancestry-specific association signals at the locus or different degrees of LD across ancestries with a true, ungenotyped causal variant. In addition, this could also reflect the modest power to detect common variant associations of weak effect. The current study is similar in size to the QTGEN and QTSCD studies, and it is perhaps not unexpected that different equally powered studies will identify different common variants when multiple variants exist at a locus, as has now been observed in many large-scale genetic association studies. Additional studies are needed to identify the causal variants and genes. Although the most significant associations were observed with SNPs in potential regulatory regions upstream of NOS1AP and ATP1B1 (http://genome.ucsc.edu/ENCODE/), associations could be mediated by causal variants in longer-range LD blocks or located in regulatory motifs influencing more distant genes. However, NOS1AP and ATP1B1 are strong candidate genes; NOS1AP encodes a protein that may interact with neuronal nitric oxide synthase to accelerate cardiac repolarization by inhibition of L-type calcium channels, 41 whereas ATP1B1 encodes the cardiac β-subunit of the membrane-bound Na, K-ATPase that is essential in the maintenance of the myocardial resting membrane potential, for which the α-subunit is targeted by digoxin. 42
Potential Clinical Implications
QT interval is a strong determinant of arrhythmia risk. Substantial heritability estimates (h 2 ) have been reported for QT interval in individuals of both European and African ancestry, ranging from 0.35 in individuals of European ancestry 9 to 0.41 in African Americans, 10 after adjustment for basic covariates including age, sex, and RR interval. A large proportion of QT variability has been shown to be explained by genetic factors, up to 40%, and about half of this was recently shown to be explained by common genetic variants. 43 In the present and previous studies, 15 we have shown that electrocardiographic markers of conduction and repolarization are not associated with genetic ancestry. These findings suggest that the reported ethnic differences in risk of cardiac arrhythmia GWA indicates genome-wide association; SNP, single-nucleotide polymorphism; and CAF, coded allele frequency. All SNPs are noncoding. Positions are on the forward strand from the reference sequence in National Center for Biotechnology Information (NCBI) build 35. SNP IDs refer to dbSNP. All SNPs are on chromosome 1. Alleles are shown as coded/noncoded. CAF refers to coded allele frequency. N eff refers to the effective sample size in the meta-analysis, defined as N×R 2 and reflects the loss of power with poor imputation compared with the total sample size. Effects are milliseconds/coded allele copy with SE within parentheses. Results of heterogeneity tests are presented as the probability value for Cochran's Q test (Q) and the I 2 statistic. may not be explained by an excess of common or rare variants influencing cardiac repolarization, but this has not been systematically tested. Indeed, in GWA studies, we identify many of the same genetic associations with QT interval in individuals of African ancestry as have been found among individuals of European ancestry. Ancestral differences in arrhythmia risk might therefore be mediated by differences that do not impact electrophysiological properties of global repolarization or conduction.
Single polymorphisms have limited predictive ability individually and are unlikely to individually have clinical use. However, each novel locus can provide novel insights into pathophysiology and potentially therapeutic targets. Our analysis only found 2 genome-wide significant loci even though our sample size was similar to 2 previous studies in individuals of European ancestry, which identified 10 loci each. 32, 33 Such a discrepancy could reflect the greater heterogeneity in populations of African ancestry or that admixed populations have lower effective sample sizes if locus-specific ancestry is associated with differing LD patterns. Individuals of African ancestry have been shown to exhibit greater heterozygosity with more rare variants, lower proportion of common variants, and shorter-range LD patterns, 44, 45 resulting in lower coverage and power of GWA approaches compared with Europeanderived populations.
Strengths and Limitations
In forming a consortium of large, population-based cohort studies of African American participants, our study was well powered to detect substantial ancestral and genetic effects and allowed linear modeling of ancestry on QT interval with adjustment for major covariates. Furthermore, our use of multiple African American population cohorts collected at several different locations makes our study likely to provide a broader coverage of African American populations.
Our study also has limitations that merit consideration. First, our results cannot rule out a smaller effect of ancestry on QT interval duration. Second, participants with extreme repolarization abnormalities may not have survived to the baseline visit of the cohorts studied. This limitation is likely to be of small impact, as participants of most cohorts were in the early middle age. Third, we did not have information on several clinical factors that are known to influence QT interval, including concurrent medications, myocardial ischemia, heart failure, and time point on the day of ECG recording, which potentially explain a large proportion of QT variation. Although such factors are unlikely to be determined by genotypic effects and thus unlikely to bias our observations, they could potentially dilute the effect of genetic associations.
In conclusion, our results establish that QT interval does not differ substantially by ancestry and extended the association of genetic polymorphisms at several loci including NOS1AP and ATP1B1 to populations of African ancestry. Future studies aimed at identifying mediators of excess genetic arrhythmia risk in African Americans should focus on factors other than cardiac conduction and repolarization.
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